{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:54:46Z","timestamp":1793858086880,"version":"4.6.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.xphs.2024.10.028","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T16:31:04Z","timestamp":1729701064000},"page":"497-506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Impact of dissolution medium pH and ionization state of the drug on the release performance of amorphous solid dispersions"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8378-4140","authenticated-orcid":false,"given":"Anura S.","family":"Indulkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Alex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5527-2781","authenticated-orcid":false,"given":"Geoff G.Z.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xphs.2024.10.028_bib0001","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/pr.112.005660","article-title":"Strategies to address low drug solubility in discovery and development","volume":"65","author":"Williams","year":"2013","journal-title":"Pharmacol Rev"},{"issue":"9","key":"10.1016\/j.xphs.2024.10.028_bib0002","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1002\/jps.23826","article-title":"Enhancements and limits in drug membrane transport using supersaturated solutions of poorly water soluble drugs","volume":"103","author":"Raina","year":"2014","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2024.10.028_bib0003","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1007\/s11095-015-1712-4","article-title":"Impact of solubilizing additives on supersaturation and membrane transport of drugs","volume":"32","author":"Raina","year":"2015","journal-title":"Pharm Res"},{"issue":"6","key":"10.1016\/j.xphs.2024.10.028_bib0004","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1021\/acs.molpharmaceut.6b00202","article-title":"Exploiting the phenomenon of liquid\u2013liquid phase separation for enhanced and sustained membrane transport of a poorly water-soluble drug","volume":"13","author":"Indulkar","year":"2016","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2024.10.028_bib0005","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1021\/acs.molpharmaceut.8b01261","article-title":"Insights into the dissolution mechanism of ritonavir-copovidone amorphous solid dispersions: importance of congruent release for enhanced performance","volume":"16","author":"Indulkar","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2024.10.028_bib0006","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2018.11.003","article-title":"Relationship between amorphous solid dispersion in vivo absorption and in vitro dissolution: phase behavior during dissolution, speciation, and membrane mass transport","volume":"292","author":"Wilson","year":"2018","journal-title":"J Control Rel"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.028_bib0007","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1021\/acs.molpharmaceut.5b00652","article-title":"Dissolution of danazol amorphous solid dispersions: supersaturation and phase behavior as a function of drug loading and polymer type","volume":"13","author":"Jackson","year":"2016","journal-title":"Mol Pharm"},{"issue":"9","key":"10.1016\/j.xphs.2024.10.028_bib0008","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/j.xphs.2015.10.008","article-title":"Polymeric amorphous solid dispersions: a review of amorphization, crystallization, stabilization, solid-state characterization, and aqueous solubilization of biopharmaceutical classification system class II drugs","volume":"105","author":"Baghel","year":"2016","journal-title":"J Pharm Sci"},{"issue":"12","key":"10.1016\/j.xphs.2024.10.028_bib0009","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1007\/s11095-009-9974-3","article-title":"Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions","volume":"26","author":"Rumondor","year":"2009","journal-title":"Pharm Res"},{"issue":"12","key":"10.1016\/j.xphs.2024.10.028_bib0010","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1007\/s11095-017-2265-5","article-title":"Phase behavior of ritonavir amorphous solid dispersions during hydration and dissolution","volume":"34","author":"Purohit","year":"2017","journal-title":"Pharm Res"},{"issue":"12","key":"10.1016\/j.xphs.2024.10.028_bib0011","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1021\/acs.molpharmaceut.9b01025","article-title":"Insights into the dissolution behavior of ledipasvir\u2013copovidone amorphous solid dispersions: role of drug loading and intermolecular interactions","volume":"16","author":"Que","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2024.10.028_bib0012","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2019.01.039","article-title":"Congruent release of drug and polymer: a \u201csweet spot\u201d in the dissolution of amorphous solid dispersions","volume":"298","author":"Saboo","year":"2019","journal-title":"J Control Rel"},{"issue":"2","key":"10.1016\/j.xphs.2024.10.028_bib0013","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1021\/mp500573z","article-title":"Glass\u2013liquid phase separation in highly supersaturated aqueous solutions of telaprevir","volume":"12","author":"Mosquera-Giraldo","year":"2015","journal-title":"Mol Pharm"},{"issue":"9","key":"10.1016\/j.xphs.2024.10.028_bib0014","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/j.xphs.2019.04.006","article-title":"Effect of amorphous nanoparticle size on bioavailability of anacetrapib in dogs","volume":"108","author":"Kesisoglou","year":"2019","journal-title":"J Pharm Sci"},{"issue":"7","key":"10.1016\/j.xphs.2024.10.028_bib0015","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1021\/acs.molpharmaceut.7b00338","article-title":"Impact of drug-rich colloids of itraconazole and HPMCAS on membrane flux in vitro and oral bioavailability in rats","volume":"14","author":"Stewart","year":"2017","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.028_bib0016","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijpharm.2009.12.014","article-title":"Possible reduction of effective thickness of intestinal unstirred water layer by particle drifting effect","volume":"387","author":"Sugano","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2024.10.028_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122120","article-title":"Role of surfactants in improving release from higher drug loading amorphous solid dispersions","volume":"625","author":"Correa-Soto","year":"2022","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2024.10.028_bib0018","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1021\/acs.molpharmaceut.9b01272","article-title":"Congruent release of drug and polymer from amorphous solid dispersions: insights into the role of drug-polymer hydrogen bonding, surface crystallization, and glass transition","volume":"17","author":"Saboo","year":"2020","journal-title":"Mol Pharm"},{"issue":"9","key":"10.1016\/j.xphs.2024.10.028_bib0019","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1021\/acs.molpharmaceut.1c00419","article-title":"Impact of drug\u2013polymer intermolecular interactions on dissolution performance of copovidone-based amorphous solid dispersions","volume":"18","author":"Que","year":"2021","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2024.10.028_bib0020","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11095-022-03183-4","article-title":"Role of surfactants on release performance of amorphous solid dispersions of ritonavir and copovidone","volume":"39","author":"Indulkar","year":"2022","journal-title":"Pharm Res"},{"issue":"12","key":"10.1016\/j.xphs.2024.10.028_bib0021","doi-asserted-by":"crossref","first-page":"6451","DOI":"10.1021\/acs.molpharmaceut.3c00827","article-title":"Effect of buffer pH and concentration on the dissolution rates of sodium indomethacin\u2013copovidone and indomethacin\u2013copovidone amorphous solid dispersions","volume":"20","author":"Chiang","year":"2023","journal-title":"Mol Pharm"},{"issue":"10","key":"10.1016\/j.xphs.2024.10.028_bib0022","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s11095-016-1969-2","article-title":"Initial drug dissolution from amorphous solid dispersions controlled by polymer dissolution and drug-polymer interaction","volume":"33","author":"Chen","year":"2016","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2024.10.028_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120087","article-title":"Impact of polymer type, ASD loading and polymer-drug ratio on ASD tablet disintegration and drug release","volume":"592","author":"Zhang","year":"2021","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2024.10.028_bib0024","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1021\/mp500660m","article-title":"Drug\u2013polymer\u2013water interaction and its implication for the dissolution performance of amorphous solid dispersions","volume":"12","author":"Chen","year":"2015","journal-title":"Mol Pharm"},{"issue":"8","key":"10.1016\/j.xphs.2024.10.028_bib0025","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1021\/acs.molpharmaceut.2c00250","article-title":"Water-resistant drug\u2013polymer interaction contributes to the formation of nano-species during the dissolution of felodipine amorphous solid dispersions","volume":"19","author":"Liu","year":"2022","journal-title":"Mol Pharm"},{"issue":"7","key":"10.1016\/j.xphs.2024.10.028_bib0026","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1021\/acs.molpharmaceut.5b00056","article-title":"pH-dependent liquid\u2013liquid phase separation of highly supersaturated solutions of weakly basic drugs","volume":"12","author":"Indulkar","year":"2015","journal-title":"Mol Pharm"},{"issue":"3\u20134","key":"10.1016\/j.xphs.2024.10.028_bib0027","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/star.201400181","article-title":"Effect of pH and ionic strength on the electrical charge and particle size distribution of starch nanocrystal suspensions","volume":"67","author":"Romdhane","year":"2015","journal-title":"Starch - St\u00e4rke"},{"key":"10.1016\/j.xphs.2024.10.028_bib0028","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.colsurfa.2013.01.023","article-title":"Adsorption of organic acids on magnetite nanoparticles, pH-dependent colloidal stability and salt tolerance","volume":"435","author":"Tomb\u00e1cz","year":"2013","journal-title":"Colloids Surf A: Physicochem Eng Asp"},{"issue":"12","key":"10.1016\/j.xphs.2024.10.028_bib0029","doi-asserted-by":"crossref","first-page":"4518","DOI":"10.1021\/acs.molpharmaceut.5b00705","article-title":"Hydrogen bonding interactions in amorphous indomethacin and its amorphous solid dispersions with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl acetate) studied using 13C solid-state NMR","volume":"12","author":"Yuan","year":"2015","journal-title":"Mol Pharm"},{"issue":"9","key":"10.1016\/j.xphs.2024.10.028_bib0030","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1021\/acs.molpharmaceut.1c00325","article-title":"Effect of counterions on dissolution of amorphous solid dispersions studied by surface area normalized dissolution","volume":"18","author":"Chen","year":"2021","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2024.10.028_bib0031","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejpb.2022.04.002","article-title":"Combining enabling formulation strategies to generate supersaturated solutions of delamanid: in situ salt formation during amorphous solid dispersion fabrication for more robust release profiles","volume":"174","author":"Duong","year":"2022","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.028_bib0032","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1021\/acs.molpharmaceut.1c00805","article-title":"Increasing drug loading of weakly acidic telmisartan in amorphous solid dispersions through pH modification during hot-melt extrusion","volume":"19","author":"Thompson","year":"2022","journal-title":"Mol Pharm"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924004787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924004787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T01:36:27Z","timestamp":1734744987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354924004787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0022354924004787"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2024.10.028","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of dissolution medium pH and ionization state of the drug on the release performance of amorphous solid dispersions","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2024.10.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}